同種造血幹細胞移植予後予測を目指したKMT2A関連異常骨髄系腫瘍のゲノミクス解析

• Project/Area Number: 25K18917
• Research Category: Grant-in-Aid for Early-Career Scientists
• Allocation Type: Multi-year Fund
• Review Section: Basic Section 50020:Tumor diagnostics and therapeutics-related
• Research Institution: Tokyo Metropolitan Hospital Organization Tokyo Metropolitan Komagome Hospital
• Principal Investigator: 貞任 大地 地方独立行政法人東京都立病院機構東京都立駒込病院(臨床研究室), 臨床研究・治験センター, バイオインフォマティシャン (20868773)
• Project Period (FY): 2025-04-01 – 2028-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000); Fiscal Year 2027: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000); Fiscal Year 2026: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000); Fiscal Year 2025: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)